Resmed (RMD) Treasury Shares (2010 - 2026)

Resmed's Treasury Shares history runs 17 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• Quarterly Treasury Shares rose 30.59% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 30.59% YoY) and the FY2025 annual result came in at $2.1 billion, up 16.92% from the prior year.
• Treasury Shares was $2.6 billion for Q1 2026 at Resmed, up from $2.4 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $45.8 million in Q1 2026 and bottomed at $41.8 million in Q1 2022.
• A 5-year average of $42.9 million and a median of $42.4 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2026, when it surged 30.59%.
• Resmed's Treasury Shares stood at $1.6 billion in 2022, then grew by 3.08% to $1.7 billion in 2023, then rose by 13.45% to $1.9 billion in 2024, then rose by 26.45% to $2.4 billion in 2025, then climbed by 7.36% to $2.6 billion in 2026.
• Business Quant data shows RMD's Treasury Shares at $2.6 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.2 billion in Q3 2025.